ATArchna Talwar

Archna Talwar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Archna Talwar has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Avni Nayyar

    Department of Chemistry, Isabella Thoburn PG College, University of Lucknow, Lucknow, India

    4 shared publications
  • Manaal Zahera

    Department of Biotechnology, Era University, Lucknow, India

    4 shared publications
  • Shruti Anand

    Department of Chemistry, Isabella Thoburn PG College, University of Lucknow, Lucknow, India

    4 shared publications
  • Farzana Mahdi

    Department of Personalised Medicine, Era University, Lucknow, India

    3 shared publications
  • Ahmed M. Alharbi

    Department of Medical Laboratory Science, College of Applied Medical Sciences, University of Ha’il, Hail, Saudi Arabia

    2 shared publications
  • Avni Nayyar

    Department of Chemistry, Isabella Thoburn College, University of Lucknow, Lucknow-226007, India

    2 shared publications

Latest Publications

  • Open Access

    Green fabrication and biological evaluation of glucose-conjugated silver nanoparticles derived from Bixa orellana seeds

    by Shruti Anand, Avni Nayyar, Manaal Zahera, Tarun Kumar Upadhyay, Reem Binsuwaidan, Afsheen Fatima, Meenu Verma, Farzana Mahdi, Nawaf Alshammari, Safia Obaidur Rab, et al.

  • Open Access

    Green synthesis of silver nanoparticles using Morus nigra leaf extract and their mechanistic insights into antimicrobial and anticancer effects

    by Manaal Zahera, Avni Nayyar, Shruti Anand, Shireen Masood, Priya Sharad, Monisha Banerjee, Farzana Mahdi, Lina I. Alnajjar, Mohd Saeed, Nawaf Alshammari, et al.

    This study reports the preliminary biological evaluation of glucose-capped silver nanoparticles synthesized using an aqueous leaf extract of Morus nigra . LC-MS analysis of the methanolic extract provided a preliminary metabolite profile of the plant, confirming the presence of bioactive secondary metabolites. The silver nanoparticles were characterized using various analytical techniques, such as UV-Vis Spectroscopy, FTIR, FESEM, TEM, and DLS/Zeta. 2,2-diphenyl-1-picrylhydrazyl (DPPH) and phosphomolybdate assays demonstrated significantly higher antioxidant potential of GC-AgNPs than aqueous leaf extract. GC-AgNPs reported 57% inhibition (IC 50 ≈ 65 μg/mL) and a total antioxidant capacity of approximately 446.15 mg AAE/g at 250 μg/mL in the DPPH and phosphomolybdate assays, respectively. The selective antimicrobial dosing against Escherichia coli and Staphylococcus aureus was determined based on delivery modes. A clear zone of inhibition of 8.33 mm and 12.66 mm against E. coli was reported in the disc diffusion method. Contrastingly, S. aureus showed inhibition zones of 14 mm and 16 mm in the well diffusion method. The cytotoxic evaluation against SiHa cervical cancer cells using the MTT assay revealed an IC 50 value of 52 μg/mL for nanoparticles compared to aqueous leaf extract (81 μg/mL). The findings suggest a possible intracellular delivery mechanism; however, this remains hypothetical and requires further validation, including nanoparticle uptake, oxidative-stress pathways, intracellular localization, and others.


  • Open Access

    Biogenic metal-oxide nanoparticles synthesized from Morus nigra leaf extract: A dual therapeutic approach for antioxidant and antidiabetic applications

    by Avni Nayyar, Shruti Anand, Manaal Zahera, Tarun Kumar Upadhyay, Amit Baran Sharangi, Samra Siddiqui, Ali Alkhathami, Vivek Kumar, Archna Talwar

    The study reports the novel synthesis of glucose-stabilized zinc oxide nanoparticles (G-ZNPs) using an aqueous leaf extract of Morus nigra as a reducing agent and glucose as a stabilizing agent to improve nanoparticle stability and biocompatibility. X-Ray diffraction (XRD) analysis determined the hexagonal wurtzite structure. An optical band gap of 5.34 eV, corresponding to 229 nm, was observed for G-ZNPs. The zeta potential value of -16.9 mV indicated a stable net negative charge. The highest % inhibition for G-ZNPs was reported to be 73% at 100 µg/mL (IC 50 =53±0.17 µg/mL by the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay. In vitro α-amylase inhibition assay showed IC 50 =88±0.02 µg/mL for G-ZNPs and IC 50 =127±0.03 µg/mL for metformin, highlighting the antidiabetic potential of the nanoparticles. A significant upregulation of antioxidant enzymes, including superoxide dismutase (SOD) and catalase (CAT), following a 28-day treatment was reported in in vivo antioxidant studies using Zebrafish ( Danio rerio ).

  • Open Access

    Bioconjugated ZnO Nanoparticles from Solanum nigrum Leaves: Monosaccharide Unlocks Potent Antidiabetic and Antioxidant Power

    by Archna Talwar, Avni Nayyar, Shruti Anand, Manaal Zahera, Prachi Singh

    The research focuses on conjugating biogenically synthesized zinc oxide nanoparticles (ZnO NPs) with glucose to analyse the inhibitory potential of ZnO nanoparticles against α-amylase. This study proposes, for the first time, that glucose-modified ZnO NPs may alleviate oxidative stress that hinders the formation of advanced glycation end products (AGEs). ZnO NPs are synthesized by using an aqueous leaf extract of Solanum nigrum and characterized using different characterization techniques such as UV-Vis spectroscopy, FESEM, TEM, FTIR, DLS/Zeta and X-ray diffraction. The ZnO NPs were assessed for in vitro antioxidant potential, confirming better antioxidant potential of GC-NP (IC50 = 45.7 ± 0.18 µg/mL) than UC-NP (IC50 = 53.4 ± 0.031 µg/mL). The bio-functionalized ZnO NPs were evaluated for their α-amylase inhibitory activity, showing enhanced inhibition by GC-NP (IC50 = 521 ± 0.004 µg/mL) compared to UC-NP (IC50 = 530 ± 0.01 µg/mL), attributed to tailored surface interactions. Overall, the study highlights that biofunctionalized ZnO NPs exhibit promising potential as a future drug candidate for targeted drug delivery in diabetes management.


  • Open Access

    Role of glucose bioencapsulation in modulating the antioxidant and enzymatic activity of ZnO nanoparticles synthesized via Bixa orellana seeds

    by Shruti Anand, Avni Nayyar, Manaal Zahera, Prachi Singh, Farzana Mahdi, Archna Talwar


  • Open Access

    Antidiabetic Potential of Phytochemicals Found in Vernonia amygdalina

    by Archna Talwar, Neha Chakraborty, Manaal Zahera, Shruti Anand, Irshad Ahmad, Samra Siddiqui, Avni Nayyar, Ashanul Haque, Mohd Saeed

    Type 2 diabetes mellitus (T2DM), or insulin-independent diabetes mellitus, is a worldwide health concern. Diabetes affects roughly 415 million individuals worldwide, with 193 million undiagnosed cases. The number of people afflicted in the following decades is predicted to double. Although various synthetic medications are currently available to treat/manage T2DM, their side effects compel researchers to seek novel treatment options. Because of their affinity for biological receptors and broad bioactivity, nature has long been a source of innovative medication. V. amygdalina is one of the numerous natural productswith antidiabetic properties. Several studies have shown that the extracts have antidiabetic effects in vitro and in vivo. This review examined the antidiabetic and pharmacokinetic characteristics of phytoconstituents found in V. amygdalina.